BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 35381341)

  • 21. Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation.
    Balcells E; Gimeno-Santos E; de Batlle J; Ramon MA; Rodríguez E; Benet M; Farrero E; Ferrer A; Guerra S; Ferrer J; Sauleda J; Barberà JA; Agustí À; Rodriguez-Roisin R; Gea J; Antó JM; Garcia-Aymerich J;
    BMC Pulm Med; 2015 Jan; 15():4. PubMed ID: 25595204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. External Validation Of The Updated ADO Score In COPD Patients From The Birmingham COPD Cohort.
    Keene SJ; Jordan RE; Franssen FM; de Vries F; Martin J; Sitch A; Turner AM; Dickens AP; Fitzmaurice D; Adab P
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2395-2407. PubMed ID: 31749613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
    Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
    NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in the lifetime risk of COPD exacerbation requiring hospitalisation.
    Lykkegaard J; dePont Christensen R; Davidsen JR; Støvring H; Andersen M; Søndergaard J
    Eur Respir J; 2013 Oct; 42(4):964-71. PubMed ID: 23429915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease.
    Bertens LC; Reitsma JB; Moons KG; van Mourik Y; Lammers JW; Broekhuizen BD; Hoes AW; Rutten FH
    Int J Chron Obstruct Pulmon Dis; 2013; 8():493-9. PubMed ID: 24143086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia: a population-based, cohort study.
    Stephenson A; Seitz DP; Fischer HD; Gruneir A; Bell CM; Gershon AS; Fu L; Anderson GM; Austin PC; Rochon PA; Gill SS
    Drugs Aging; 2012 Mar; 29(3):213-223. PubMed ID: 22332932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routine laboratory tests can predict in-hospital mortality in acute exacerbations of COPD.
    Asiimwe AC; Brims FJ; Andrews NP; Prytherch DR; Higgins BR; Kilburn SA; Chauhan AJ
    Lung; 2011 Jun; 189(3):225-32. PubMed ID: 21556787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic obstructive pulmonary disease exacerbation episodes derived from electronic health record data validated using clinical trial data.
    Sperrin M; Webb DJ; Patel P; Davis KJ; Collier S; Pate A; Leather DA; Pimenta JM
    Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1369-1376. PubMed ID: 31385428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospitalisation for COPD in Puglia: the role of hospital discharge database to estimate prevalence and incidence.
    Trerotoli P; Bartolomeo N; Moretti AM; Serio G
    Monaldi Arch Chest Dis; 2008 Sep; 69(3):94-106. PubMed ID: 19065843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using the BODE Index and Comorbidities to Predict Health Utilization Resources in Chronic Obstructive Pulmonary Disease.
    Li CL; Lin MH; Chen PS; Tsai YC; Shen LS; Kuo HC; Liu SF
    Int J Chron Obstruct Pulmon Dis; 2020; 15():389-395. PubMed ID: 32110007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self management for patients with chronic obstructive pulmonary disease.
    Zwerink M; Brusse-Keizer M; van der Valk PD; Zielhuis GA; Monninkhof EM; van der Palen J; Frith PA; Effing T
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD002990. PubMed ID: 24665053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Combined Chronic Obstructive Pulmonary Disease Status and Systemic Inflammation on Outcome of Advanced NSCLC: Multicenter Retrospective Cohort Study.
    Lim JU; Kang HS; Yeo CD; Kim JS; Park CK; Kim YH; Kim JW; Kim SJ; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3323-3334. PubMed ID: 33363365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
    Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determining prognosis in acute exacerbation of COPD.
    Flattet Y; Garin N; Serratrice J; Perrier A; Stirnemann J; Carballo S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():467-475. PubMed ID: 28203070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting Hospitalization Due to COPD Exacerbations in Swedish Primary Care Patients Using Machine Learning - Based on the ARCTIC Study.
    Ställberg B; Lisspers K; Larsson K; Janson C; Müller M; Łuczko M; Kjøller Bjerregaard B; Bacher G; Holzhauer B; Goyal P; Johansson G
    Int J Chron Obstruct Pulmon Dis; 2021; 16():677-688. PubMed ID: 33758504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying high-risk hospitalised chronic kidney disease patient using electronic health records for serious illness conversation.
    Yeoh LY; Seow YY; Tan HC
    Ann Acad Med Singap; 2022 Mar; 51(3):161-169. PubMed ID: 35373239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UK National COPD Audit 2003: Impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation.
    Price LC; Lowe D; Hosker HS; Anstey K; Pearson MG; Roberts CM;
    Thorax; 2006 Oct; 61(10):837-42. PubMed ID: 16449268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score Identifies Chronic Obstructive Pulmonary Disease Patients at High Mortality Risk.
    Blagev DP; Collingridge DS; Rea S; Horne BD; Press VG; Churpek MM; Carey KA; Mularski RA; Zeng S; Arjomandi M
    Front Med (Lausanne); 2018; 5():173. PubMed ID: 29942803
    [No Abstract]   [Full Text] [Related]  

  • 39. Hospitalised exacerbations of chronic obstructive pulmonary disease: adherence to guideline recommendations in an Australian teaching hospital.
    Sha J; Worsnop CJ; Leaver BA; Vagias C; Kinsella P; Rahman MA; McDonald CF
    Intern Med J; 2020 Apr; 50(4):453-459. PubMed ID: 31157943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a claims-based prediction model for COPD severity.
    Macaulay D; Sun SX; Sorg RA; Yan SY; De G; Wu EQ; Simonelli PF
    Respir Med; 2013 Oct; 107(10):1568-77. PubMed ID: 23806285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.